临床误诊误治2023,Vol.36Issue(12) :128-133.DOI:10.3969/j.issn.1002-3429.2023.12.026

欣康胶囊对气阴两虚兼血瘀证冠心病稳定型心绞痛患者疗效及炎性因子的影响

Effect of Xinkang Capsule on Stable Angina Pectoris of Coronary Heart Disease with Qi-yin Deficiency and Blood Stasis Syndrome and Inflammato-ry Factors

孙秋月 孙伟 李永倩 曹清慧 徐淼
临床误诊误治2023,Vol.36Issue(12) :128-133.DOI:10.3969/j.issn.1002-3429.2023.12.026

欣康胶囊对气阴两虚兼血瘀证冠心病稳定型心绞痛患者疗效及炎性因子的影响

Effect of Xinkang Capsule on Stable Angina Pectoris of Coronary Heart Disease with Qi-yin Deficiency and Blood Stasis Syndrome and Inflammato-ry Factors

孙秋月 1孙伟 1李永倩 1曹清慧 1徐淼1
扫码查看

作者信息

  • 1. 053000 河北 衡水,衡水市中医医院内分泌科
  • 折叠

摘要

目的 观察欣康胶囊治疗冠心病稳定型心绞痛(气阴两虚兼血瘀证)患者的效果.方法 选取2018 年7 月—2020 年12 月期间88 例冠心病稳定型心绞痛,中医辨证为气阴两虚兼血瘀证,随机分为2 组,各44 例.对照组常规西药治疗,观察组在对照组基础上联合欣康胶囊治疗,均连续治疗8 周.比较2 组心绞痛严重程度变化、心绞痛疗效、西雅图心绞痛量表(SAQ)评分、心绞痛发作情况、硝酸甘油停减率及血清炎性因子水平.结果 治疗后,观察组加拿大心血管病学会分级优于对照组,心绞痛发作次数少于对照组,每次发作持续时间短于对照组,SAQ各维度评分高于对照组,血清超敏C反应蛋白、肿瘤坏死因子-α、白细胞介素-6 水平低于对照组(P<0.05).观察组上述指标治疗前后差值变化幅度大于对照组(P<0.05).观察组总有效率和硝酸甘油减停率(88.64%和 79.55%)均高于对照组(68.18%和54.55%)(P<0.05).不良反应发生率2 组间对比无明显差异(P>0.05).结论 欣康胶囊能提高气阴两虚兼血瘀证冠心病稳定型心绞痛的临床疗效,改善心绞痛发作程度,降低炎性因子水平.

Abstract

Objective To observe the effect of Xinkang capsule in the treatment of patients with stable angina pecto-ris of coronary heart disease(CHD)(Qi-yin deficiency with blood stasis).Methods A total of 88 patients with stable angi-na pectoris of CHD from July 2018 to December 2020 were selected,all of which were dialectically classified as Qi-yin defi-ciency with blood stasis,and were randomly divided into two groups,with 44 patients in each group.The control group was treated with conventional Western medicine,and the observation group was treated with Xinkang capsule on the basis of the control group.Both groups were treated for 8 consecutive weeks.The changes of angina severity,angina curative effect,Seat-tle angina questionnaire(SAQ)score,angina pectoris attack,reduction rate of nitroglycerin and serum inflammatory factor levels were compared between the two groups.Results After treatment,the Canadian Cardiovascular Society classification of the observation group was better than that of the control group,the frequency and duration of angina pectoris attacks were less or shorter than those of the control group.The SAQ scores were higher than those of the control group,and the levels of serum hypersensitive C-reactive protein,interleukin-6 and tumor necrosis factor-α were lower than those of the control group(P<0.05).The difference of the above indexes before and after treatment in the observation group was greater than that in the con-trol group(P<0.05).The total effective rate and the reduction rate of nitroglycerin in the observation group(88.64%and 79.55%)were higher than those in the control group(68.18%and54.55%)(P<0.05).There was no significant differ-ence in the incidence of adverse reactions between groups(P>0.05).Conclusion Xinkang capsule can improve the clini-cal effect in stable angina pectoris of CHD with Qi-yin deficiency combined with blood stasis,attenuate the severity of angina pectoris,and reduce the level of inflammatory factors.

关键词

冠心病/心绞痛,稳定型/欣康胶囊/气阴两虚/血瘀/超敏C反应蛋白/白细胞介素-6/肿瘤坏死因子-α

Key words

Coronary disease/Angina,stable/Xinkang capsule/Qi-yin deficiency/Blood stasis/Hypersensitive C-reactive protein/Interleukin-6/Tumor necrosis factor-α

引用本文复制引用

基金项目

河北省中医药管理局科研计划项目(2019339)

出版年

2023
临床误诊误治
解放军白求恩国际和平医院

临床误诊误治

CSTPCD
影响因子:0.914
ISSN:1002-3429
参考文献量23
段落导航相关论文